Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation

Clinical trial NCT00691470 · UNKNOWN

Trial details

NCT number: NCT00691470
Sponsor: ARYx Therapeutics
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Atrial Fibrillation Atrial Flutter Venous Thromboembolic Disease Myocardial Infarction Cardiomyopathy

Start date: 2008-05-01
Primary completion: 2009-06-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.